trial
as of 2026-07-01Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCTId NCT00231894
at a glance
Phase 4 · Completed
Enrollment 56 (actual)
Sponsored by Nathan Kline Institute for Psychiatric Research
Primary completion 2010-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
56 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2005-05
Primary completion
2010-01
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
Nathan Kline Institute for Psychiatric ResearchLead Sponsor
Investigators
1
Robert C. Smith, MD, PhDPrincipal Investigator
Sites
1 total
New York, United States
Facts & assertions
4 sourced
Enrollment
56
Phase
PHASE4
Primary Completion Date
2010-01
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person